PNPLA3 and metabolic dysfunction-associated steatotic liver disease: As the variation in PNPLA3 contributes to ancestry-related differences in hepatic fat content and susceptibility to NAFLD, consistently the weight loss is effective in decreasing liver fat in subjects who are homozygous for the rs738409 PNPLA3 G or C allele [80].